Summary & Overview
HCPCS L8670: Vascular Graft Material, Synthetic, Implant
HCPCS Level II code L8670 designates a synthetic vascular graft material intended for implantation during vascular reconstructive or bypass procedures. Nationally, this supply code is relevant to hospitals, ambulatory surgical centers, and surgical supply chains because it affects billing for implantable vascular devices used in arterial and venous repair or replacement. The code is important for accurate device identification, claims processing, and tracking implantable supply utilization.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for L8670, the typical settings where the graft is used, and the payer mix addressed in the analysis. The publication also summarizes available benchmarks, payer coverage patterns, and recent policy updates affecting implantable vascular graft supplies where available.
This summary provides clinicians, billing specialists, and policy analysts with a clear description of the code, who pays for it, and what to expect in terms of documentation and site-of-service implications. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code L8670 describes vascular graft material, synthetic, implant. This code represents the supply of a synthetic vascular graft used to replace or bypass sections of blood vessels.
-
Service type: Implantable vascular graft supply
-
Typical site of service: Hospital operating room, ambulatory surgical center, or other inpatient/outpatient surgical setting where vascular implant procedures are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old with peripheral arterial disease or aneurysmal disease requiring arterial reconstruction. The patient presents with limb ischemia, rest pain, or a symptomatic aneurysm and is evaluated by a vascular surgeon. After imaging (duplex ultrasound, CT angiography, or angiography) confirms an occlusive lesion or aneurysm unsuitable for endovascular-only repair, the operative plan is for open arterial bypass or graft replacement using a synthetic vascular graft material (L8670). The workflow includes preoperative medical optimization, informed consent, intraoperative implantation of the synthetic graft (for example, femoropopliteal bypass or aortic graft replacement), postoperative monitoring in PACU or ICU depending on acuity, and follow-up vascular assessments (wound checks, graft patency imaging). Typical sites of service are the inpatient operating room, ambulatory surgery center for selected lower-risk cases, or hospital outpatient surgery department. Common clinical scenarios include infected or occluded native vessel repair, bypass for critical limb ischemia, or replacement of an aortic segment with a synthetic conduit.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Primary procedure | When L8670 is reported as the primary service on the claim |